Trademarkia Logo

United Kingdom

£
Trademark Search
ENLAZA THERAPEUTICS

View On IPO.GOV.UK

Registered

on 12 Jun 2023

Last Applicant/ Owned by

Enlaza Therapeutics, Inc.

11099 North Torrey Pines Road, Suite 280

La Jolla, California, , 92037

Serial Number

UK00003921792 filed on 12th Jun 2023

Registration Number

UK00003921792 registered on
8th Sept 2023

Correspondent Information

Lane IP Limited

The Forum, St Paul's, 33 Gutter Lane

London,

EC2V 8AS

ENLAZA THERAPEUTICS

chemical products for use in industry and science; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical Read More

Classification Information

Class [1]
Chemical Products

Chemical products for use in industry and science; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; antibody reagents for scientific purposes; in-vivo diagnostic reagents for scientific or research use; enzymes for scientific use; cell culture media for use in scientific research; active chemical ingredients for use in the manufacture of anti-cancer drugs; laboratory chemicals, namely, an antibody reagent used for the detection of cancerous tumors; antibodies for research use.

Class [5]
Pharmaceutical Products

Pharmaceutical products, preparations, and substances for the treatment of cancer; cancer therapeutics, namely, anti-cancer preparations; novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer and tumors; biological preparations and substances for the treatment, diagnosis, detection, and prevention of cancer; pharmaceutical products consisting of covalent protein biologics; pharmaceutical products, namely, covalent protein drugs; pharmaceuticals products consisting of synthetic biology enabled covalent protein biologics; pharmaceutical products consisting of covalent protein drugs; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals.

Class [42]
Computer & Software Services & Scientific Services

Research and development in the field of covalent protein biologics; medical and scientific research in the field of cancer treatment and diagnosis; pharmaceutical research and development; research and development of pharmaceuticals and biologicals in the field of cancer therapeutics; research and development in the field of synthetic biology enabled covalent therapeutics and covalent protein drugs; research and development for the purpose of selective covalent modification of proteins; research and development in the field of oncology, namely, development of a biotechnology platform to create covalent protein biologics for treating cancer; research and development in the field of covalent protein drugs, namely, development of a platform technology for identification of small-molecule and biologic therapeutics for treating cancer and targeting tumors; conducting clinical trials for others in the field of cancer therapeutics; biotechnology testing services, namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, and analysis; research and development services in the field of antibody-drug conjugates, T cells, natural killer (NK) cells, and macrophage engaging antibodies; research and development services for the purpose of antibody engineering, namely, custom design and engineering of antibodies.

Mark Details

Serial Number

UK00003921792

Mark Type

Word

Kind of mark

Individual